Syntekabio: Execution of single sales and supply contract
AI reading
★★★ Bullish · Contract win
Signed single-sale and supply contract for antibody optimization
Key figures: 계약금액 5.3억·매출대비 15.46%
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Syntekabio
- 09.04 ★★ [Amendment] Material Fact Report (Decision on Paid-in Capital Increase)
- 09.03 ★★ [Amendment] Material Fact Report (Decision on Paid-in Capital Increase)
- 09.02 ★★ [Amendment] Material Fact Report (Decision on Paid-in Capital Increase)
- 08.31 ★★ Decision on third-party allocated capital increase to secure operating funds
- 08.28 ★★ [Amended] Execution of share pledge agreement involving change in largest shareholder
For information only. Not investment advice.